penicillin v has been researched along with cefuroxime in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (10.00) | 18.7374 |
| 1990's | 6 (20.00) | 18.2507 |
| 2000's | 15 (50.00) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jetlund, O; Thurmann-Nielsen, E; Walstad, RA | 1 |
| Andrew, M; Brandtzaeg, P; Gaustad, P; Halstensen, A; Hjortdahl, P; Høiby, EA | 1 |
| Chavanet, P; Gouyon, JB; Guetat, F; Portier, H | 1 |
| Aronovitz, GH; Disney, FA; Ginsburg, C; Pichichero, ME; Stillerman, M | 1 |
| Cocchetto, DM; Evans, EC; Gooch, WM; Higbee, MD; Swenson, E | 1 |
| Forsgren, A; Walder, M | 1 |
| Aronovitz, GH; Gooch, WM; Kaplan, EL; Kumar, A; McLinn, SE; Ossi, MJ; Pichichero, ME | 1 |
| Grahn, E; Henning, C; Holm, S; Lomberg, H; Staley, H | 1 |
| Arnez, M; Pleterski-Rigler, D; Radsel-Medvescek, A; Ruzić-Sabljić, E; Strle, F | 1 |
| Adam, D; Helmerking, M; Scholz, H | 1 |
| Hansen, H; Hoiby, N; Johansen, HK; Pers, C | 1 |
| Ahcan, J; Arnez, M; Pleterski-Rigler, D; Radsel-Medvescek, A; Ruzić-Sabljić, E; Strle, F | 1 |
| Gompels, M; Prosser, DP | 1 |
| Scholz, H | 1 |
| Frimodt-Møller, N; Jensen, TG; Madsen, H; Pedersen, C; Qvist, N; Salomon, S | 1 |
| Arnez, M | 1 |
| Alimoradi, J; Haraszuk, J; Jeppesen, J; Lisby, G | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Caugant, DA; Fredlund, H; Hedberg, ST; Nicolas, P; Olcén, P; Unemo, M | 1 |
| Chanteperdrix, V; Croizé, J; Nordmann, P; Poirel, L; Potron, A | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for penicillin v and cefuroxime
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 trial(s) available for penicillin v and cefuroxime
| Article | Year |
|---|---|
Five day treatment of pharyngotonsillitis with cefpodoxime proxetil.
Topics: Adolescent; Adult; Cefpodoxime Proxetil; Ceftizoxime; Cefuroxime; Female; Humans; Male; Middle Aged; Penicillin V; Pharyngitis; Pilot Projects; Prodrugs; Streptococcus pyogenes; Tonsillitis | 1990 |
A multicenter, randomized, single-blind evaluation of cefuroxime axetil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis.
Topics: Adolescent; Cefuroxime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Male; Penicillin Resistance; Penicillin V; Pharyngitis; Random Allocation; Streptococcal Infections; Streptococcus pyogenes; Time Factors | 1987 |
Efficacy of cefuroxime axetil suspension compared with that of penicillin V suspension in children with group A streptococcal pharyngitis.
Topics: Acute Disease; Age Factors; Cefuroxime; Child; Child, Preschool; Ethnicity; Female; Humans; Male; Patient Compliance; Penicillin V; Pharyngitis; Sex Factors; Streptococcal Infections; Streptococcus pyogenes; Suspensions | 1993 |
Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish Study Group.
Topics: beta-Lactamases; Cefuroxime; Cephalosporins; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Penicillin V; Penicillins; Pharyngitis; Pharynx; Prodrugs; Recurrence; Saliva; Streptococcal Infections; Streptococcus; Suspensions; Tonsillitis; Treatment Failure | 1995 |
Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans.
Topics: Adolescent; Cefuroxime; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema Chronicum Migrans; Female; Humans; Infant; Male; Penicillin V; Penicillins; Prospective Studies; Treatment Outcome | 1999 |
Comparison of short-course (5 day) cefuroxime axetil with a standard 10 day oral penicillin V regimen in the treatment of tonsillopharyngitis.
Topics: Adenoids; Adolescent; Cefuroxime; Cephalosporins; Child; Child, Preschool; Demography; Drug Tolerance; Follow-Up Studies; Glomerulonephritis; Humans; Incidence; Infant; Penicillin V; Penicillins; Pharyngitis; Recurrence; Rheumatic Fever; Tonsillitis | 2000 |
Excretion of beta-lactam antibiotics in sweat--a neglected mechanism for development of antibiotic resistance?
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; beta-Lactam Resistance; Ceftazidime; Ceftriaxone; Cefuroxime; Cephalosporins; Female; Humans; Injections, Intravenous; Male; Middle Aged; Penicillin G; Penicillin V; Penicillins; Sweat | 2000 |
Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil versus a 10-day course of penicillin V. results depending on the children's age.
Topics: Adolescent; Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Humans; Infant; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 2004 |
21 other study(ies) available for penicillin v and cefuroxime
| Article | Year |
|---|---|
Comparison of the serum and tissue concentrations of cefuroxime from cefuroxime axetil and phenoxymethylpenicillin in patients undergoing tonsillectomy.
Topics: Adult; Cefuroxime; Female; Half-Life; Humans; Male; Palatine Tonsil; Penicillin V; Tonsillectomy | 1991 |
[Treatment of infections caused by group A beta-hemolytic streptococci].
Topics: Adult; Cefuroxime; Child; Clindamycin; Erythromycin; Humans; Hygiene; Penicillin G; Penicillin V; Streptococcal Infections; Streptococcus pyogenes | 1990 |
Cefuroxime axetil and penicillin V compared in the treatment of group A beta-hemolytic streptococcal pharyngitis.
Topics: Adolescent; Carrier State; Cefuroxime; Cephalosporins; Child; Child, Preschool; Drug Evaluation; Female; Hemolysis; Humans; Male; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1987 |
Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Dose-Response Relationship, Drug; Doxycycline; Drug Combinations; Erythromycin; Haemophilus influenzae; Humans; Neisseria; Penicillin Resistance; Penicillin V; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Isolation of Borrelia burgdorferi sensu lato from blood of children with solitary erythema migrans.
Topics: Bacteremia; Bacteriological Techniques; Borrelia burgdorferi Group; Cefuroxime; Cephalosporins; Child; Child, Preschool; Erythema Chronicum Migrans; Female; Humans; Infant; Male; Penicillin V; Penicillins; Prospective Studies; Treatment Outcome | 2001 |
Anaphylactic shock due to cefuroxime in a patient taking penicillin prophylaxis.
Topics: Adolescent; Anaphylaxis; Anemia, Sickle Cell; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Female; Humans; Orthopedic Procedures; Penicillin V | 2002 |
[Use of antibiotics in colorectal surgery in Denmark].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Cefuroxime; Colorectal Neoplasms; Denmark; Drug Therapy, Combination; Drug Utilization Review; Elective Surgical Procedures; Emergencies; Gentamicins; Humans; Metronidazole; Penicillin V; Practice Patterns, Physicians'; Surveys and Questionnaires | 2007 |
Antibiotic treatment of children with erythema migrans.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Child; Erythema Chronicum Migrans; Humans; Penicillin V | 2007 |
[Streptococcus pyogenes infection with tonsillar focus as possible cause of septic shock].
Topics: Anti-Bacterial Agents; Cefuroxime; Clindamycin; Disseminated Intravascular Coagulation; Female; Humans; Middle Aged; Penicillin V; Shock, Septic; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 2009 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Antibiotic susceptibility and characteristics of Neisseria meningitidis isolates from the African meningitis belt, 2000 to 2006: phenotypic and genotypic perspectives.
Topics: Africa; Genotype; Humans; Meningitis, Meningococcal; Microbial Sensitivity Tests; Neisseria meningitidis; Phenotype; Sequence Analysis, DNA; Time Factors | 2009 |
Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |